Analysts' Actions: ALL, CRM, IACI, WWW

RELATED QUOTES

SymbolPriceChange
ALL55.77-0.22
CRM56.10+0.12
IACI68.67+0.04
WWW26.91-0.02

NEW YORK (TheStreet) -- CHANGE IN RATINGS

Allstate ALL was upgraded from Sell to Neutral at Goldman Sachs. Earnings outlook is improving, Goldman said.

AthenaHealth ATHN was upgraded at Morgan Stanley from Underweight to Equal-Weight. Valuation call, Morgan Stanley said.

Atmel ATML was downgraded at Capstone from Buy to Hold. Touch IC growth has likely plateaued.

CACI CAI was downgraded at Credit Suisse from Outperform to Neutral. $53 price target. Sales growth is deteriorating, Credit Suisse said.

Cooper Industries CBE was downgraded at Stifel Nicolaus from Buy to Hold. Valuation call, Stifel Nicolaus said.

Chesapeake Energy CHK was upgraded at Bernstein to Outperform. $21 price target. Company has multiple potential near-term catalysts for a rebound, Bernstein said.

Salesforce.com CRM was upgraded at Credit Suisse from Neutral to Outperform. $185 price target. Company is leveraged to a massive technology refresh, Credit Suisse said.

Curtiss-Wright NOK was downgraded at Capstone from Buy to Hold. Valuation call, Capstone said.

Davita DVA was downgraded at Robert Baird from Outperform to Neutral. Company lacks near-term catalysts, Baird said.

El Paso Electric EE was upgraded at Ladenburg Thalmann to Buy from Neutral. $33 price target. Valuation call, Ladenburg Thalmann said.

Green Mountain Coffee Roasters GMCR was downgraded at Piper Jaffray from Overweight to Neutral. Estimates were also cut, given the company's new guidance, Piper Jaffray said. $40 price target.

Hecla Mining HL was downgraded to Hold at TheStreet Ratings.

IAC/InterActiveCorp IACI was upgraded at Benchmark from Hold to Buy. $59 price target. Search and Match continue to drive solid growth, Benchmark said.

MSCI MSCI was upgraded at Credit Suisse from Neutral to Outperform. Recent weakness has created an attractive buying opportunity, Credit Suisse said. $42 price target.

Prosperity Bancshares PB was downgraded at Oppenheimer to Underperform from Perform. Valuation and interest rate environment, Oppenheimer said.

tw telecom TWTC was upgraded at Oppenheimer to Outperform from Perform. $30 price target. Unique network capability and accelerating growth, Oppenheimer said.

Vanguard Natural Resources VNR was upgraded to Buy at TheStreet Ratings.

Wolverine World Wide WWW was upgraded at DA Davidson from Neutral to Buy. $50 price target. Recent acquisition should add to earnings, DA Davidson said.

Stock Comments / EPS Changes

American Eagle AEO numbers were boosted at FBR Capital Markets. Shares are now seen reaching $21. Estimates were also increased, as the company is seeing higher sales growth, FBR said. Market Perform rating.

American Eagle numbers were raised at UBS. Shares are now seen reaching $21. Estimates were also increased on strong first-quarter sales and margins. Neutral rating.

Agco AGCO estimates, target were raised at Credit Suisse. Shares are now seen reaching $57. Estimates were also increased, as the company is seeing higher profits across the board, Credit Suisse said. Neutral rating.

Allergan AGN numbers were raised at Jefferies. Shares are now seen reaching $95. Estimates were also raised on remarkable long-term execution, Jefferies said. Hold rating.

Allstate numbers were raised at UBS. Shares are now seen reaching $38. Estimates were also increased as mild weather drives EPS beat, UBS said. Buy rating.

Acme Packet APKT price target was raised at Jefferies to $40. Visibility improving, Jefferies said. Buy rating.

BB&T BBT estimates, price target were boosted at Bank of America/Merrill Lynch. Shares are now seen reaching $33. Estimates were also upped, given improving fundamentals, BofA/Merrill Lynch said. Neutral rating.

CEVA Incorporated CEVA numbers were lowered at Oppenheimer. Shares are now seen reaching $25. Estimates were also lowered on first-half 2012 headwinds, Oppenheimer said. Outperform rating.

Comcast CMCSA was cut from the Focus List at Brean Murray. Valuation call, based on a $35 price target, Brean Murray said.

Concur Technologies CNQR numbers were raised at Jefferies. Shares are now seen reaching $59. Estimates were also raised on good trends, Jefferies said. Hold rating.

CVS Caremark CVS numbers were raised at UBS. Shares are now seen reaching $53. Estimates were also increased as shares are poised to move higher if no WAG/ESRX resolution, UBS said. Buy rating.

CVS/Caremark Corp. numbers were raised at Jefferies. Shares are now seen reaching $52. Estimates were also raised on a beat-and-raise quarter, Jefferies said. Buy rating.

El Paso Electric EE numbers were lowered at Jefferies. Shares are now seen reaching $34.50. Estimates were also lowered on lower forecasted rate base, Jefferies said. Buy rating.

Energizer ENR estimates, price target were raised at BMO Capital. Shares are now seen reaching $85. Estimates were also increased, as the company is realizing higher sales, BMO Capital said. Market Perform rating.

Expeditors International EXPD numbers were lowered at Jefferies. Shares are now seen reaching $49. Estimates were also lowered on yield squeeze, Jefferies said. Buy rating.

Green Mountain numbers were reduced at Keybanc. Shares are now seen reaching $45. Estimates were also cut, given the company's new guidance, Keybanc said. Buy rating.

IAC/InterActiveCorp numbers were raised at Oppenheimer. Shares are now seen reaching $63. Estimates also raised on solid future growth, Oppenheimer said. Outperform rating.

IAC/InterActiveCorp numbers were boosted at Credit Suisse. Shares are now seen reaching $58. Estimates were also raised, given higher growth at Search. Outperform rating.

Intercontinental Exchange ICE numbers were cut at BMO Capital. Estimates were reduced through 2013. OTC commissions are weak, BMO Capital said. Market Perform rating and new $150 price target.

IntercontinentalExchange numbers were lowered at UBS. Shares are now seen reaching $153. Estimates were also lowered on lower expected OTC energy commissions, UBS said. Buy rating.

JDSU JDSU numbers were cut at Citigroup. Shares are now seen reaching $16.50. Estimates were also lowered as guidance disappoints, Citi said. Buy rating.

MasterCard MA estimates, target raised at UBS. Shares are now seen reaching $457. Estimates were also increased as share wins add momentum, UBS said. Neutral rating.

Onyx Pharmaceuticals ONXX was cut from the Conviction Buy List at Goldman Sachs. Valuation call, based on a $52 price target, Goldman said.

Onyx Pharmaceuticals numbers were increased at Morgan Stanley. Estimates were raised through 2014. Company is expanding margins, Morgan Stanley said. Underweight rating and new $39 price target.

Och-Ziff Capital Management OZM numbers were lowered at Citigroup. Shares are now seen reaching $11.50. Estimates were also lowered to reflect higher share count and slightly lower AUM compounding, Citi said. Buy rating.

Petsmart PETM estimates, price target were increased at Bank of America/Merrill Lynch. Industry trends have are encouraging, BofA/Merrill said. Buy rating and new $65 price target.

Prudential Financial PRU numbers were cut at Credit Suisse. Shares are now seen reaching $62. Estimates also reduced, given recent business weakness, Credit Suisse said. Outperform rating.

Visa V estimates, price target were raised at Goldman Sachs. Shares are now seen reaching $142. Estimates were also increased, given increased consumer activity and international expansion opportunities, Goldmans aid. Buy rating.

Visa estimates, price target were increased at UBS. Shares are now seen reaching $127. Estimates were also increased to reflect solid trends, UBS said. Neutral rating.

Volcano VOLC was added to the Conviction Buy List at Goldman Sachs. Estimates were also boosted, given solid penetration of FM technology, Goldman said. $36 price target.

Whole Foods Market WFM numbers were raised at Guggenheim. Estimates were boosted through 2013. Comp sales momentum should remain healthy, Guggenheim said. Neutral rating and new $90 price target.

Whole Foods Market numbers raised at UBS. Shares are now seen reaching $104. Gross margin surprises to the upside and long-term strategy reaffirmed, UBS said. Buy rating.

Weight Watchers WTW numbers were lowered at Bank of America/Merrill Lynch. Shares are now seen reaching $82. Estimates were also cut, as lower sales are cutting into margins, BofA/Merrill said. Buy rating.

>To submit a news tip, email: tips@thestreet.com.

READERS ALSO LIKE:


Follow TheStreet on Twitter and become a fan on Facebook.

Search